Suppr超能文献

大动脉炎介入治疗后的免疫抑制治疗与血管再狭窄

Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu's arteritis.

作者信息

Park M C, Lee S W, Park Y B, Lee S K, Choi D, Shim W H

机构信息

Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun-gu, Seoul 120-752, Korea.

出版信息

Rheumatology (Oxford). 2006 May;45(5):600-5. doi: 10.1093/rheumatology/kei245. Epub 2005 Dec 13.

Abstract

OBJECTIVE

To investigate the outcome of vascular interventions and the effect of post-interventional immunosuppressive treatment on the occurrence of vascular restenosis in patients with Takayasu's arteritis (TA).

METHODS

Forty-two patients with TA who had undergone vascular intervention and had serial angiographies before and after intervention were enrolled. The demographic and clinical data were collected at the time when the interventions were performed, and the intervention modalities and post-interventional medical treatments were evaluated.

RESULTS

Sixty-three interventions were performed in 42 patients. Twenty (31.7%) interventions restenosed 24.0 +/- 21.9 months after intervention; the likelihood decreasing as time passed. Estimates of arterial patency after intervention were 90.1% at 1 yr, 75.5% at 2 yr, 68.4% at 3 yr, 61.6% at 5 yr and 49.3% at 10 yr. According to the log rank test, interventions that were performed during the stable stage of the disease (P = 0.039) and those that were followed by treatment with glucocorticoids and immunosuppressive agents (P = 0.044) were independent variables for the maintenance of arterial patency. Their hazard ratios were 0.30 and 0.41, respectively.

CONCLUSION

Restenosis occurred in 31.7% of TA patients after intervention. A lower restenosis rate was observed when the vascular interventions were performed at the stable stage and when post-interventional immunosuppressive treatment was implemented.

摘要

目的

探讨血管介入治疗的效果以及介入后免疫抑制治疗对大动脉炎(TA)患者血管再狭窄发生情况的影响。

方法

纳入42例接受血管介入治疗且在介入前后均进行了系列血管造影的TA患者。在进行介入治疗时收集人口统计学和临床数据,并对介入方式和介入后的药物治疗进行评估。

结果

42例患者共进行了63次介入治疗。20次(31.7%)介入治疗在介入后24.0±21.9个月出现再狭窄;再狭窄可能性随时间推移而降低。介入后1年、2年、3年、5年和10年的动脉通畅率估计分别为90.1%、75.5%、68.4%、61.6%和49.3%。根据对数秩检验,在疾病稳定期进行的介入治疗(P = 0.039)以及介入后接受糖皮质激素和免疫抑制剂治疗的介入治疗(P = 0.044)是维持动脉通畅的独立变量。它们的风险比分别为0.30和0.41。

结论

TA患者介入治疗后31.7%发生再狭窄。在疾病稳定期进行血管介入治疗以及实施介入后免疫抑制治疗时,观察到较低的再狭窄率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验